HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
STAA
STAAR Surgical Company
STAA's fundamentals are strong, but it looks expensive: trading at 2678x earnings, about 20 times its usual 133x. Its downside scenario is more than ten times its upside.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
STAA Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Healthy | |
| Strong |
STAA's revenue, profitability, cash flow and balance sheet are all currently healthy.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
STAA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 50x | $26.78 | — |
| Cheap | 82x | $0.82 | -97% |
| Fair | 132x | $1.32 | -95% |
| Expensive | 350x | $3.50 | -87% |
| Current | 2,678x | $26.78 | — |
Historical ranges are pointers, not guarantees.
STAA's PE is in its expensive range at 2678x. If earnings grow as analysts expect, today's price would be 50x next year's earnings, in its cheap range.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
STAA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| Low |
STAA has the edge over HIMS on the outlook, with more favorable earnings expectations.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has swung to a loss: it lost $0.83 per share over the past year, after a profit the year before.
STAA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.54 | +5306% |
| Q3 2026 | $0.01 | +$1.96 |
| Q2 2026 | $0.08 | +$2.01 |
| Q1 2026 | -$0.42 | +$1.02 |
| Q4 2025 | -$1.62 | -$1.21 |
| Q3 2025 | -$1.95 | -543% |
| Q2 2025 | -$1.93 | -668% |
| Q1 2025 | -$1.44 | -565% |
| Q4 2024 | -$0.41 | -195% |
STAA has the edge over HIMS on earnings quality, reporting a profit while its opponent remains loss making.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over STAA on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS's operating margin was −7.4% last quarter, down 9.4 points from the same quarter a year ago.
STAA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $83.4M | -12% |
| Q2 2026 | $93.5M | +111% |
| Q1 2026 | $93.5M | +120% |
| Q4 2025 | $57.8M | +18% |
| Q3 2025 | $94.7M | +6.9% |
| Q2 2025 | $44.3M | -55% |
| Q1 2025 | $42.6M | -45% |
| Q4 2024 | $49M | -36% |
STAA's revenue is growing: $83M last quarter, down 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 6.5% | -13 points |
| Q2 2026 | 11% | +78 points |
| Q1 2026 | 8.5% | +143 points |
| Q4 2025 | -40% | +18 points |
| Q3 2025 | 20% | +13 points |
| Q2 2025 | -68% | -80 points |
| Q1 2025 | -135% | -132 points |
| Q4 2024 | -57% | -71 points |
STAA has the edge over HIMS on profitability, with a higher operating margin.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over STAA on cash flow, with more consistent year-over-year improvement.
STAA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26.4M | +1379% |
| Q2 2026 | $19.2M | +$48.2M |
| Q1 2026 | -$22.1M | -$14.9M |
| Q4 2025 | -$5.6M | -$508K |
| Q3 2025 | $1.8M | +$4.2M |
| Q2 2025 | -$29M | -$12.4M |
| Q1 2025 | -$7.2M | -144% |
| Q4 2024 | -$5.1M | -118% |
STAA's free cash flow has turned positive after three years mostly in the red: $18M over the past year.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over STAA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
STAA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -52K shares |
| 1 year | +1.8% | +900K shares |
| 3 years | +4.2% | +2.1M shares |
| 5 years | +3.7% | +1.9M shares |
| Available history | +9.7% | +4.6M shares |
STAA has 51M diluted shares, up 1.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
| Q3 2025 | $2M |
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
STAA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -13.9x | Net Cash |
| Q2 2026 | -6.7x | Net Cash |
| Q3 2024 | -5.2x | Net Cash |
| Q2 2024 | -6.1x | Net Cash |
| Q1 2023 | -2.3x | Net Cash |
| Q4 2022 | -1.8x | Net Cash |
| Q3 2022 | -2.4x | Net Cash |
| Q2 2022 | -4.2x | Net Cash |
STAA has more cash than debt.
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
STAA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.9 | Neutral |
| Stochastic | 69.4 | Neutral |
STAA's weekly RSI is 58 (neutral) and its Stochastic is 69 (neutral).
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
STAA PE vs Healthcare Sector
| Metric | STAA | Sector median | Relative |
|---|---|---|---|
| PE | 2,678x | 26x | 10,260% above |
| PE % | 100 | 29 | 71 pts above |
STAA is trading at 2678x earnings, a 10260% premium to the Healthcare sector's median of 26x.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
STAA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $23.1 | 16% above |
| 20 week MA | $23.9 | 12% above |
| 50 week MA | $23.7 | 13% above |
| 100 week MA | $22.8 | 18% above |
| 200 week MA | $33.3 | 19% below |
STAA has the edge over HIMS on trend strength, trading above more of its moving averages.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS's yearly returns have swung widely, from +198% in 2024 to −56% in 2021. It's down 42% so far in 2026.
STAA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $36.5 | $81.4 | +123% |
| 2021 | $81.4 | $96.3 | +18% |
| 2022 | $96.3 | $48.4 | -50% |
| 2023 | $48.4 | $31.2 | -36% |
| 2024 | $31.2 | $24.2 | -22% |
| 2025 | $24.2 | $23.4 | -3.6% |
| 2026 YTD | $23.4 | $26.8 | +15% |
STAA has the edge over HIMS on returns for 2026, with the stronger performance.